Prohibition Partners Announces New Growth Marketing Platform PPX, Welcoming Heidi Whitman as its MD
Prohibition Partners pairs a decade of cannabis market infrastructure with the international network of PPX’s new Managing Director.

200 articles
What’s changing in cannabis law: our editors’ articles, and announcements straight from regulators, courts, governments and companies.
Prohibition Partners pairs a decade of cannabis market infrastructure with the international network of PPX’s new Managing Director.

MADISON, Wis. (September 4, 2026) The Indigenous Cannabis Industry Association (ICIA) was awarded the Minority Cannabis Business Association (MCBA) Community Partnership Award. The prestigious award recognizes advocacy…

RN Collins has written a new series (3) of 18 articles for cannabis law report on 2026 Psychedelics & Legal Issues.

Exports from Canada contributed to 61% of all medical cannabis Australia imported in 2025, according to the newest figures from the country’s cannabis regulator.

August 20, 2026 – Season 3, LLC, of Kalamazoo, in coordination with the Michigan Cannabis Regulatory Agency (CRA), is voluntarily recalling certain Nuggz Nectar Infused Drink 200mg marijuana-infused edible products.

August 12, 2026 – In response to the positive feedback from the statewide municipality summits held by the Cannabis Regulatory Agency (CRA), and in keeping with its commitment to engage in transparent communication with…

The reported resubmission of the New Drug Application will initiate a new evaluation of the treatment’s safety and efficacy for potential FDA approval

Governor Hochul today signed legislation designed to strengthen New York’s regulated cannabis market. S.10113/A.11217 supports small businesses and advances one of the state’s fastest-growing industries, marking an important step…

, Aug. 4, 2026 /PRNewswire/ — Psilera Inc. (“Psilera”), a leading biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic therapies, today announced its fall conference schedule.

B) I wouldn’t like to know who the worst companies in the US are!

Optimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression. The export marks Optimi’s third commercial shipment since launching the 5mg psilocybin capsules in September 2025.

WORCESTER—Six months after the Massachusetts Cannabis Control Commission (Commission) approved final regulations for Social Consumption Establishments in the Commonwealth, four internal working groups continue to make progress…

Melbourne, Victoria Jun 16, 2026 (Issuewire.com) – At a time when Australia is attracting unprecedented international attention for its leadership in psychedelic-assisted therapies, the inaugural International Psychedelic…

Grand opening celebration planned for Fourth of July weekend alongside the tribe’s annual “Rock the Sky” celebration featuring live music, fireworks, food trucks, and carnival rides
